AstraZeneca - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of Phase 3 clinical study of SK's COVID-19 vaccine candidate, GBP510, in combination ...

1 September 2021 News AstraZeneca | COVID-19 vaccine

Continue Reading →

News

New data at ESC Congress 2021 showcase AstraZeneca’s leading cardiovascular, renal and metabolic portfolio

At this year's European Society of Cardiology (ESC) Congress (27-30 August), AstraZeneca is sharing ...

25 August 2021 News AstraZeneca | Brilinta

Continue Reading →

News

US rejects AZ and FibroGen’s anaemia drug roxadustat

The US Food and Drug Administration (US) has handed AstraZeneca a complete response letter (CRL) regarding its anaemia drug roxadustat. AZ had submitted a new dru...

13 August 2021 News anaemia drug | AstraZeneca

Continue Reading →

News

AZ’s Forxiga gains EC, MHRA approvals for chronic kidney disease

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved by the European Commission for the treatment of chronic ...

11 August 2021 News AstraZeneca | chronic kidney disease

Continue Reading →

News

Enhertu improves progression-free survival in breast cancer trial

Positive topline results from a Phase III trial for Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu have shown that the HER2-directed antibody drug conju...

11 August 2021 News AstraZeneca | breast cancer

Continue Reading →

News

AstraZeneca partners with Cambridge Institute for Sustainability Leadership to launch unique sustainability project in Kenya

Today at the 71st World Health Assembly, AstraZeneca will announce a new sustainability project in partnership with the Cambridge Institute for Sustainability Leader...

22 May 2018 News AstraZeneca | Cambridge

Continue Reading →